Global Platelet-Rich Plasma Injection Market Growth 2022-2028
The global market for Platelet-Rich Plasma Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Platelet-Rich Plasma Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Platelet-Rich Plasma Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Platelet-Rich Plasma Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Platelet-Rich Plasma Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Platelet-Rich Plasma Injection players cover Seikagaku Corporation, Zimmer Biomet Holdings, Orlin & Cohen, Dr. Reddy's Laboratories and Chugai Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Platelet-Rich Plasma Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Platelet-Rich Plasma Injection market, with both quantitative and qualitative data, to help readers understand how the Platelet-Rich Plasma Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Platelet-Rich Plasma Injection market and forecasts the market size by Type (Leukocyte-rich (LR)-PRP, Leukocyte-poor (LP)-PRP and Others), by Application (Hospital, Clinic and Pharmacy,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Leukocyte-rich (LR)-PRP
Leukocyte-poor (LP)-PRP
Others
Segmentation by application
Hospital
Clinic
Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Seikagaku Corporation
Zimmer Biomet Holdings
Orlin & Cohen
Dr. Reddy's Laboratories
Chugai Pharmaceutical
Flexion Therapeutics
Sanofi
Relievus
Teva Pharmaceutical Industries
Wright Medical Group
Anika Therapeutics
Bioventus
Ferring Pharmaceuticals
Pfizer
Chapter Introduction
Chapter 1: Scope of Platelet-Rich Plasma Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Platelet-Rich Plasma Injection market size (sales and revenue) and CAGR, Platelet-Rich Plasma Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Platelet-Rich Plasma Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Platelet-Rich Plasma Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Platelet-Rich Plasma Injection market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Seikagaku Corporation, Zimmer Biomet Holdings, Orlin & Cohen, Dr. Reddy's Laboratories, Chugai Pharmaceutical, Flexion Therapeutics, Sanofi, Relievus and Teva Pharmaceutical Industries, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Platelet-Rich Plasma Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Platelet-Rich Plasma Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Platelet-Rich Plasma Injection by Country/Region, 2017, 2022 & 2028
2.2 Platelet-Rich Plasma Injection Segment by Type
2.2.1 Leukocyte-rich (LR)-PRP
2.2.2 Leukocyte-poor (LP)-PRP
2.2.3 Others
2.3 Platelet-Rich Plasma Injection Sales by Type
2.3.1 Global Platelet-Rich Plasma Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Platelet-Rich Plasma Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Platelet-Rich Plasma Injection Sale Price by Type (2017-2022)
2.4 Platelet-Rich Plasma Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Platelet-Rich Plasma Injection Sales by Application
2.5.1 Global Platelet-Rich Plasma Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Platelet-Rich Plasma Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Platelet-Rich Plasma Injection Sale Price by Application (2017-2022)
3 Global Platelet-Rich Plasma Injection by Company
3.1 Global Platelet-Rich Plasma Injection Breakdown Data by Company
3.1.1 Global Platelet-Rich Plasma Injection Annual Sales by Company (2020-2022)
3.1.2 Global Platelet-Rich Plasma Injection Sales Market Share by Company (2020-2022)
3.2 Global Platelet-Rich Plasma Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Platelet-Rich Plasma Injection Revenue by Company (2020-2022)
3.2.2 Global Platelet-Rich Plasma Injection Revenue Market Share by Company (2020-2022)
3.3 Global Platelet-Rich Plasma Injection Sale Price by Company
3.4 Key Manufacturers Platelet-Rich Plasma Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Platelet-Rich Plasma Injection Product Location Distribution
3.4.2 Players Platelet-Rich Plasma Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Platelet-Rich Plasma Injection by Geographic Region
4.1 World Historic Platelet-Rich Plasma Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Platelet-Rich Plasma Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Platelet-Rich Plasma Injection Annual Revenue by Geographic Region
4.2 World Historic Platelet-Rich Plasma Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Platelet-Rich Plasma Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Platelet-Rich Plasma Injection Annual Revenue by Country/Region
4.3 Americas Platelet-Rich Plasma Injection Sales Growth
4.4 APAC Platelet-Rich Plasma Injection Sales Growth
4.5 Europe Platelet-Rich Plasma Injection Sales Growth
4.6 Middle East & Africa Platelet-Rich Plasma Injection Sales Growth
5 Americas
5.1 Americas Platelet-Rich Plasma Injection Sales by Country
5.1.1 Americas Platelet-Rich Plasma Injection Sales by Country (2017-2022)
5.1.2 Americas Platelet-Rich Plasma Injection Revenue by Country (2017-2022)
5.2 Americas Platelet-Rich Plasma Injection Sales by Type
5.3 Americas Platelet-Rich Plasma Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Platelet-Rich Plasma Injection Sales by Region
6.1.1 APAC Platelet-Rich Plasma Injection Sales by Region (2017-2022)
6.1.2 APAC Platelet-Rich Plasma Injection Revenue by Region (2017-2022)
6.2 APAC Platelet-Rich Plasma Injection Sales by Type
6.3 APAC Platelet-Rich Plasma Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Platelet-Rich Plasma Injection by Country
7.1.1 Europe Platelet-Rich Plasma Injection Sales by Country (2017-2022)
7.1.2 Europe Platelet-Rich Plasma Injection Revenue by Country (2017-2022)
7.2 Europe Platelet-Rich Plasma Injection Sales by Type
7.3 Europe Platelet-Rich Plasma Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Platelet-Rich Plasma Injection by Country
8.1.1 Middle East & Africa Platelet-Rich Plasma Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Platelet-Rich Plasma Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Platelet-Rich Plasma Injection Sales by Type
8.3 Middle East & Africa Platelet-Rich Plasma Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Platelet-Rich Plasma Injection
10.3 Manufacturing Process Analysis of Platelet-Rich Plasma Injection
10.4 Industry Chain Structure of Platelet-Rich Plasma Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Platelet-Rich Plasma Injection Distributors
11.3 Platelet-Rich Plasma Injection Customer
12 World Forecast Review for Platelet-Rich Plasma Injection by Geographic Region
12.1 Global Platelet-Rich Plasma Injection Market Size Forecast by Region
12.1.1 Global Platelet-Rich Plasma Injection Forecast by Region (2023-2028)
12.1.2 Global Platelet-Rich Plasma Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Platelet-Rich Plasma Injection Forecast by Type
12.7 Global Platelet-Rich Plasma Injection Forecast by Application
13 Key Players Analysis
13.1 Seikagaku Corporation
13.1.1 Seikagaku Corporation Company Information
13.1.2 Seikagaku Corporation Platelet-Rich Plasma Injection Product Offered
13.1.3 Seikagaku Corporation Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Seikagaku Corporation Main Business Overview
13.1.5 Seikagaku Corporation Latest Developments
13.2 Zimmer Biomet Holdings
13.2.1 Zimmer Biomet Holdings Company Information
13.2.2 Zimmer Biomet Holdings Platelet-Rich Plasma Injection Product Offered
13.2.3 Zimmer Biomet Holdings Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Zimmer Biomet Holdings Main Business Overview
13.2.5 Zimmer Biomet Holdings Latest Developments
13.3 Orlin & Cohen
13.3.1 Orlin & Cohen Company Information
13.3.2 Orlin & Cohen Platelet-Rich Plasma Injection Product Offered
13.3.3 Orlin & Cohen Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Orlin & Cohen Main Business Overview
13.3.5 Orlin & Cohen Latest Developments
13.4 Dr. Reddy's Laboratories
13.4.1 Dr. Reddy's Laboratories Company Information
13.4.2 Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Product Offered
13.4.3 Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dr. Reddy's Laboratories Main Business Overview
13.4.5 Dr. Reddy's Laboratories Latest Developments
13.5 Chugai Pharmaceutical
13.5.1 Chugai Pharmaceutical Company Information
13.5.2 Chugai Pharmaceutical Platelet-Rich Plasma Injection Product Offered
13.5.3 Chugai Pharmaceutical Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chugai Pharmaceutical Main Business Overview
13.5.5 Chugai Pharmaceutical Latest Developments
13.6 Flexion Therapeutics
13.6.1 Flexion Therapeutics Company Information
13.6.2 Flexion Therapeutics Platelet-Rich Plasma Injection Product Offered
13.6.3 Flexion Therapeutics Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Flexion Therapeutics Main Business Overview
13.6.5 Flexion Therapeutics Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Platelet-Rich Plasma Injection Product Offered
13.7.3 Sanofi Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 Relievus
13.8.1 Relievus Company Information
13.8.2 Relievus Platelet-Rich Plasma Injection Product Offered
13.8.3 Relievus Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Relievus Main Business Overview
13.8.5 Relievus Latest Developments
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Information
13.9.2 Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Product Offered
13.9.3 Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Teva Pharmaceutical Industries Main Business Overview
13.9.5 Teva Pharmaceutical Industries Latest Developments
13.10 Wright Medical Group
13.10.1 Wright Medical Group Company Information
13.10.2 Wright Medical Group Platelet-Rich Plasma Injection Product Offered
13.10.3 Wright Medical Group Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Wright Medical Group Main Business Overview
13.10.5 Wright Medical Group Latest Developments
13.11 Anika Therapeutics
13.11.1 Anika Therapeutics Company Information
13.11.2 Anika Therapeutics Platelet-Rich Plasma Injection Product Offered
13.11.3 Anika Therapeutics Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Anika Therapeutics Main Business Overview
13.11.5 Anika Therapeutics Latest Developments
13.12 Bioventus
13.12.1 Bioventus Company Information
13.12.2 Bioventus Platelet-Rich Plasma Injection Product Offered
13.12.3 Bioventus Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Bioventus Main Business Overview
13.12.5 Bioventus Latest Developments
13.13 Ferring Pharmaceuticals
13.13.1 Ferring Pharmaceuticals Company Information
13.13.2 Ferring Pharmaceuticals Platelet-Rich Plasma Injection Product Offered
13.13.3 Ferring Pharmaceuticals Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ferring Pharmaceuticals Main Business Overview
13.13.5 Ferring Pharmaceuticals Latest Developments
13.14 Pfizer
13.14.1 Pfizer Company Information
13.14.2 Pfizer Platelet-Rich Plasma Injection Product Offered
13.14.3 Pfizer Platelet-Rich Plasma Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Pfizer Main Business Overview
13.14.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Platelet-Rich Plasma Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Platelet-Rich Plasma Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Leukocyte-rich (LR)-PRP
Table 4. Major Players of Leukocyte-poor (LP)-PRP
Table 5. Major Players of Others
Table 6. Global Platelet-Rich Plasma Injection Sales by Type (2017-2022) & (K Units)
Table 7. Global Platelet-Rich Plasma Injection Sales Market Share by Type (2017-2022)
Table 8. Global Platelet-Rich Plasma Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Platelet-Rich Plasma Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Platelet-Rich Plasma Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Platelet-Rich Plasma Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Platelet-Rich Plasma Injection Sales Market Share by Application (2017-2022)
Table 13. Global Platelet-Rich Plasma Injection Revenue by Application (2017-2022)
Table 14. Global Platelet-Rich Plasma Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Platelet-Rich Plasma Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Platelet-Rich Plasma Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Platelet-Rich Plasma Injection Sales Market Share by Company (2020-2022)
Table 18. Global Platelet-Rich Plasma Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Platelet-Rich Plasma Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Platelet-Rich Plasma Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Platelet-Rich Plasma Injection Producing Area Distribution and Sales Area
Table 22. Players Platelet-Rich Plasma Injection Products Offered
Table 23. Platelet-Rich Plasma Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Platelet-Rich Plasma Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Platelet-Rich Plasma Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Platelet-Rich Plasma Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Platelet-Rich Plasma Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Platelet-Rich Plasma Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Platelet-Rich Plasma Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Platelet-Rich Plasma Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Platelet-Rich Plasma Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Platelet-Rich Plasma Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Platelet-Rich Plasma Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Platelet-Rich Plasma Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Platelet-Rich Plasma Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Platelet-Rich Plasma Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Platelet-Rich Plasma Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Platelet-Rich Plasma Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Platelet-Rich Plasma Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Platelet-Rich Plasma Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Platelet-Rich Plasma Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Platelet-Rich Plasma Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Platelet-Rich Plasma Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Platelet-Rich Plasma Injection Sales by Type (2017-2022) & (K Units)
Table 47. APAC Platelet-Rich Plasma Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Platelet-Rich Plasma Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Platelet-Rich Plasma Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Platelet-Rich Plasma Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Platelet-Rich Plasma Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Platelet-Rich Plasma Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Platelet-Rich Plasma Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Platelet-Rich Plasma Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Platelet-Rich Plasma Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Platelet-Rich Plasma Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Platelet-Rich Plasma Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Platelet-Rich Plasma Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Platelet-Rich Plasma Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Platelet-Rich Plasma Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Platelet-Rich Plasma Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Platelet-Rich Plasma Injection Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Platelet-Rich Plasma Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Platelet-Rich Plasma Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Platelet-Rich Plasma Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Platelet-Rich Plasma Injection
Table 67. Key Market Challenges & Risks of Platelet-Rich Plasma Injection
Table 68. Key Industry Trends of Platelet-Rich Plasma Injection
Table 69. Platelet-Rich Plasma Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Platelet-Rich Plasma Injection Distributors List
Table 72. Platelet-Rich Plasma Injection Customer List
Table 73. Global Platelet-Rich Plasma Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Platelet-Rich Plasma Injection Sales Market Forecast by Region
Table 75. Global Platelet-Rich Plasma Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Platelet-Rich Plasma Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Platelet-Rich Plasma Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Platelet-Rich Plasma Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Platelet-Rich Plasma Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Platelet-Rich Plasma Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Platelet-Rich Plasma Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Platelet-Rich Plasma Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Platelet-Rich Plasma Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Platelet-Rich Plasma Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Platelet-Rich Plasma Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Platelet-Rich Plasma Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Platelet-Rich Plasma Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Platelet-Rich Plasma Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Platelet-Rich Plasma Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Platelet-Rich Plasma Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Platelet-Rich Plasma Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Platelet-Rich Plasma Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Seikagaku Corporation Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Seikagaku Corporation Platelet-Rich Plasma Injection Product Offered
Table 95. Seikagaku Corporation Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Seikagaku Corporation Main Business
Table 97. Seikagaku Corporation Latest Developments
Table 98. Zimmer Biomet Holdings Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Zimmer Biomet Holdings Platelet-Rich Plasma Injection Product Offered
Table 100. Zimmer Biomet Holdings Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Zimmer Biomet Holdings Main Business
Table 102. Zimmer Biomet Holdings Latest Developments
Table 103. Orlin & Cohen Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Orlin & Cohen Platelet-Rich Plasma Injection Product Offered
Table 105. Orlin & Cohen Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Orlin & Cohen Main Business
Table 107. Orlin & Cohen Latest Developments
Table 108. Dr. Reddy's Laboratories Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Product Offered
Table 110. Dr. Reddy's Laboratories Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Dr. Reddy's Laboratories Main Business
Table 112. Dr. Reddy's Laboratories Latest Developments
Table 113. Chugai Pharmaceutical Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Chugai Pharmaceutical Platelet-Rich Plasma Injection Product Offered
Table 115. Chugai Pharmaceutical Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Chugai Pharmaceutical Main Business
Table 117. Chugai Pharmaceutical Latest Developments
Table 118. Flexion Therapeutics Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Flexion Therapeutics Platelet-Rich Plasma Injection Product Offered
Table 120. Flexion Therapeutics Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Flexion Therapeutics Main Business
Table 122. Flexion Therapeutics Latest Developments
Table 123. Sanofi Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Platelet-Rich Plasma Injection Product Offered
Table 125. Sanofi Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. Relievus Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Relievus Platelet-Rich Plasma Injection Product Offered
Table 130. Relievus Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Relievus Main Business
Table 132. Relievus Latest Developments
Table 133. Teva Pharmaceutical Industries Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Product Offered
Table 135. Teva Pharmaceutical Industries Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Teva Pharmaceutical Industries Main Business
Table 137. Teva Pharmaceutical Industries Latest Developments
Table 138. Wright Medical Group Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Wright Medical Group Platelet-Rich Plasma Injection Product Offered
Table 140. Wright Medical Group Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Wright Medical Group Main Business
Table 142. Wright Medical Group Latest Developments
Table 143. Anika Therapeutics Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Anika Therapeutics Platelet-Rich Plasma Injection Product Offered
Table 145. Anika Therapeutics Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Anika Therapeutics Main Business
Table 147. Anika Therapeutics Latest Developments
Table 148. Bioventus Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Bioventus Platelet-Rich Plasma Injection Product Offered
Table 150. Bioventus Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Bioventus Main Business
Table 152. Bioventus Latest Developments
Table 153. Ferring Pharmaceuticals Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. Ferring Pharmaceuticals Platelet-Rich Plasma Injection Product Offered
Table 155. Ferring Pharmaceuticals Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Ferring Pharmaceuticals Main Business
Table 157. Ferring Pharmaceuticals Latest Developments
Table 158. Pfizer Basic Information, Platelet-Rich Plasma Injection Manufacturing Base, Sales Area and Its Competitors
Table 159. Pfizer Platelet-Rich Plasma Injection Product Offered
Table 160. Pfizer Platelet-Rich Plasma Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Pfizer Main Business
Table 162. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Platelet-Rich Plasma Injection
Figure 2. Platelet-Rich Plasma Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Platelet-Rich Plasma Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Platelet-Rich Plasma Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Platelet-Rich Plasma Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Leukocyte-rich (LR)-PRP
Figure 10. Product Picture of Leukocyte-poor (LP)-PRP
Figure 11. Product Picture of Others
Figure 12. Global Platelet-Rich Plasma Injection Sales Market Share by Type in 2021
Figure 13. Global Platelet-Rich Plasma Injection Revenue Market Share by Type (2017-2022)
Figure 14. Platelet-Rich Plasma Injection Consumed in Hospital
Figure 15. Global Platelet-Rich Plasma Injection Market: Hospital (2017-2022) & (K Units)
Figure 16. Platelet-Rich Plasma Injection Consumed in Clinic
Figure 17. Global Platelet-Rich Plasma Injection Market: Clinic (2017-2022) & (K Units)
Figure 18. Platelet-Rich Plasma Injection Consumed in Pharmacy
Figure 19. Global Platelet-Rich Plasma Injection Market: Pharmacy (2017-2022) & (K Units)
Figure 20. Global Platelet-Rich Plasma Injection Sales Market Share by Application (2017-2022)
Figure 21. Global Platelet-Rich Plasma Injection Revenue Market Share by Application in 2021
Figure 22. Platelet-Rich Plasma Injection Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Platelet-Rich Plasma Injection Revenue Market Share by Company in 2021
Figure 24. Global Platelet-Rich Plasma Injection Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Platelet-Rich Plasma Injection Revenue Market Share by Geographic Region in 2021
Figure 26. Global Platelet-Rich Plasma Injection Sales Market Share by Region (2017-2022)
Figure 27. Global Platelet-Rich Plasma Injection Revenue Market Share by Country/Region in 2021
Figure 28. Americas Platelet-Rich Plasma Injection Sales 2017-2022 (K Units)
Figure 29. Americas Platelet-Rich Plasma Injection Revenue 2017-2022 ($ Millions)
Figure 30. APAC Platelet-Rich Plasma Injection Sales 2017-2022 (K Units)
Figure 31. APAC Platelet-Rich Plasma Injection Revenue 2017-2022 ($ Millions)
Figure 32. Europe Platelet-Rich Plasma Injection Sales 2017-2022 (K Units)
Figure 33. Europe Platelet-Rich Plasma Injection Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Platelet-Rich Plasma Injection Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Platelet-Rich Plasma Injection Revenue 2017-2022 ($ Millions)
Figure 36. Americas Platelet-Rich Plasma Injection Sales Market Share by Country in 2021
Figure 37. Americas Platelet-Rich Plasma Injection Revenue Market Share by Country in 2021
Figure 38. United States Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Platelet-Rich Plasma Injection Sales Market Share by Region in 2021
Figure 43. APAC Platelet-Rich Plasma Injection Revenue Market Share by Regions in 2021
Figure 44. China Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Platelet-Rich Plasma Injection Sales Market Share by Country in 2021
Figure 51. Europe Platelet-Rich Plasma Injection Revenue Market Share by Country in 2021
Figure 52. Germany Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Platelet-Rich Plasma Injection Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Platelet-Rich Plasma Injection Revenue Market Share by Country in 2021
Figure 59. Egypt Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Platelet-Rich Plasma Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Platelet-Rich Plasma Injection in 2021
Figure 65. Manufacturing Process Analysis of Platelet-Rich Plasma Injection
Figure 66. Industry Chain Structure of Platelet-Rich Plasma Injection
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets